Abiopharma

Clinical trial NCT02403505 updates: 1. completion date: 2026-02-28 → 2026-12-28 2. primary completion date: 2026-02-28 → 2026-11-28 3. enrollment: not set → 20 participants

Clinical trial NCT04305054 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-20 → 2026-05-18 3. primary completion date: 2026-05-20 → 2026-05-18 4. enrollment: not set → 335 participants

Clinical trial NCT06824103 updates: 1. completion date: 2032-01-11 → 2031-05-23 2. enrollment: not set → 50 participants

Clinical trial NCT06333951 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2031-10-27 → 2026-11-30 3. primary completion date: 2028-10-27 → 2026-10-31 4. enrollment: not set → 49 participants

Clinical trial NCT07013474 updates: 1. completion date: 2027-05-06 → 2028-02-25 2. primary completion date: 2026-12-06 → 2027-09-27 3. enrollment: not set → 300 participants

Clinical trial NCT03890237: enrollment: not set → 4500 participants.

Clinical trial NCT06300411 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-10 → 2026-04-08 3. primary completion date: 2026-04-10 → 2026-04-08 4. enrollment: not set → 25 participants

Clinical trial NCT07607301: enrollment: not set → 96 participants.

Clinical trial NCT04064060: enrollment: not set → 665 participants.

Clinical trial NCT04896008: enrollment: not set → 173 participants.